HEADER TRANSPORT PROTEIN/MEMBRANE PROTEIN 29-OCT-10 3AQF TITLE CRYSTAL STRUCTURE OF THE HUMAN CRLR/RAMP2 EXTRACELLULAR COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: RECEPTOR ACTIVITY-MODIFYING PROTEIN 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: EXTRACELLULAR DOMAIN, UNP RESIDUES 39-139; COMPND 5 SYNONYM: CALCITONIN-RECEPTOR-LIKE RECEPTOR ACTIVITY-MODIFYING PROTEIN COMPND 6 2, CRLR ACTIVITY-MODIFYING PROTEIN 2; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: N-TERMINAL DOMAIN, UNP RESIDUES 23-136; COMPND 12 SYNONYM: CGRP TYPE 1 RECEPTOR, CALCITONIN RECEPTOR-LIKE RECEPTOR; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RAMP2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI CELL-FREE SYSTEM; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PX070809-03; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 GENE: CALCRL, CGRPR; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI CELL-FREE SYSTEM; SOURCE 15 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 16 EXPRESSION_SYSTEM_PLASMID: PX080331-02 KEYWDS TRANSMEMBRANE, GPCR, ADRENOMEDULLIN, TRAFFICKING, CLR, CGRP, KEYWDS 2 ENDOPLASMIC RETICULUM, AM-RECEPTOR, DISEASE, NEOVASCULARIZATION, CO- KEYWDS 3 ACTIVATING RECEPTOR FOR ADRENOMEDULLIN, ADRENOMEDULLIN (AM), KEYWDS 4 ENDOPLASMIC RETICULUM (ER), TRANSPORT PROTEIN-MEMBRANE PROTEIN KEYWDS 5 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.KUSANO,M.KUKIMONO-NIINO,M.SHIROUZU,T.SHINDO,S.YOKOYAMA REVDAT 2 25-JUL-12 3AQF 1 JRNL REVDAT 1 02-NOV-11 3AQF 0 JRNL AUTH S.KUSANO,M.KUKIMOTO-NIINO,N.HINO,N.OHSAWA,K.OKUDA, JRNL AUTH 2 K.SAKAMOTO,M.SHIROUZU,T.SHINDO,S.YOKOYAMA JRNL TITL STRUCTURAL BASIS FOR EXTRACELLULAR INTERACTIONS BETWEEN JRNL TITL 2 CALCITONIN RECEPTOR-LIKE RECEPTOR AND RECEPTOR JRNL TITL 3 ACTIVITY-MODIFYING PROTEIN 2 FOR ADRENOMEDULLIN-SPECIFIC JRNL TITL 4 BINDING JRNL REF PROTEIN SCI. V. 21 199 2012 JRNL REFN ISSN 0961-8368 JRNL PMID 22102369 JRNL DOI 10.1002/PRO.2003 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.62 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 6075 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.700 REMARK 3 FREE R VALUE TEST SET COUNT : 662 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 802 REMARK 3 BIN R VALUE (WORKING SET) : 0.2400 REMARK 3 BIN FREE R VALUE : 0.2770 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 11.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 102 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.027 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1462 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 30 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.67400 REMARK 3 B22 (A**2) : -6.67400 REMARK 3 B33 (A**2) : 13.34800 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM SIGMAA (A) : 0.21 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.26 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.050 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.309 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.482 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.960 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : NULL REMARK 3 BSOL : 38.88 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3AQF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 16-NOV-10. REMARK 100 THE RCSB ID CODE IS RCSB029566. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-JUL-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL26B2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9790, 0.9793, 0.9640 REMARK 200 MONOCHROMATOR : SI DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU JUPITER 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6157 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 11.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.11500 REMARK 200 FOR THE DATA SET : 20.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.25200 REMARK 200 FOR SHELL : 5.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 33.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.86 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BIS-TRIS, 30 % (V/V) PEG MME 550, REMARK 280 0.05M CALCIUM CHLORIDE, PH 6.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 59.69550 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 27.71200 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 27.71200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 29.84775 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 27.71200 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 27.71200 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 89.54325 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 27.71200 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 27.71200 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 29.84775 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 27.71200 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 27.71200 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 89.54325 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 59.69550 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1860 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 49 REMARK 465 SER A 50 REMARK 465 SER A 51 REMARK 465 GLY A 52 REMARK 465 SER A 53 REMARK 465 SER A 54 REMARK 465 GLY A 55 REMARK 465 GLN A 135 REMARK 465 PRO A 136 REMARK 465 THR A 137 REMARK 465 PHE A 138 REMARK 465 SER A 139 REMARK 465 GLY B 16 REMARK 465 SER B 17 REMARK 465 SER B 18 REMARK 465 GLY B 19 REMARK 465 SER B 20 REMARK 465 SER B 21 REMARK 465 GLY B 22 REMARK 465 GLU B 23 REMARK 465 LEU B 24 REMARK 465 GLU B 25 REMARK 465 GLU B 26 REMARK 465 SER B 27 REMARK 465 PRO B 28 REMARK 465 GLU B 29 REMARK 465 ASP B 30 REMARK 465 SER B 31 REMARK 465 ILE B 32 REMARK 465 GLN B 33 REMARK 465 LEU B 34 REMARK 465 GLY B 35 REMARK 465 GLU B 133 REMARK 465 LYS B 134 REMARK 465 VAL B 135 REMARK 465 LYS B 136 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP B 96 OG SER B 98 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP B 70 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 60 -179.21 -170.19 REMARK 500 GLN B 59 -97.55 51.72 REMARK 500 ALA B 60 71.52 32.74 REMARK 500 ALA B 80 158.80 -42.13 REMARK 500 GLN B 107 -9.85 -59.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3AQE RELATED DB: PDB REMARK 900 RECEPTOR ACTIVITY-MODIFYING PROTEIN 2 EXTRACELLULAR DOMAIN DBREF 3AQF A 56 139 UNP O60895 RAMP2_HUMAN 56 139 DBREF 3AQF B 23 136 UNP Q16602 CALRL_HUMAN 23 136 SEQADV 3AQF GLY A 49 UNP O60895 EXPRESSION TAG SEQADV 3AQF SER A 50 UNP O60895 EXPRESSION TAG SEQADV 3AQF SER A 51 UNP O60895 EXPRESSION TAG SEQADV 3AQF GLY A 52 UNP O60895 EXPRESSION TAG SEQADV 3AQF SER A 53 UNP O60895 EXPRESSION TAG SEQADV 3AQF SER A 54 UNP O60895 EXPRESSION TAG SEQADV 3AQF GLY A 55 UNP O60895 EXPRESSION TAG SEQADV 3AQF GLY B 16 UNP Q16602 EXPRESSION TAG SEQADV 3AQF SER B 17 UNP Q16602 EXPRESSION TAG SEQADV 3AQF SER B 18 UNP Q16602 EXPRESSION TAG SEQADV 3AQF GLY B 19 UNP Q16602 EXPRESSION TAG SEQADV 3AQF SER B 20 UNP Q16602 EXPRESSION TAG SEQADV 3AQF SER B 21 UNP Q16602 EXPRESSION TAG SEQADV 3AQF GLY B 22 UNP Q16602 EXPRESSION TAG SEQRES 1 A 91 GLY SER SER GLY SER SER GLY GLY THR VAL LYS ASN TYR SEQRES 2 A 91 GLU THR ALA VAL GLN PHE CYS TRP ASN HIS TYR LYS ASP SEQRES 3 A 91 GLN MSE ASP PRO ILE GLU LYS ASP TRP CYS ASP TRP ALA SEQRES 4 A 91 MSE ILE SER ARG PRO TYR SER THR LEU ARG ASP CYS LEU SEQRES 5 A 91 GLU HIS PHE ALA GLU LEU PHE ASP LEU GLY PHE PRO ASN SEQRES 6 A 91 PRO LEU ALA GLU ARG ILE ILE PHE GLU THR HIS GLN ILE SEQRES 7 A 91 HIS PHE ALA ASN CYS SER LEU VAL GLN PRO THR PHE SER SEQRES 1 B 121 GLY SER SER GLY SER SER GLY GLU LEU GLU GLU SER PRO SEQRES 2 B 121 GLU ASP SER ILE GLN LEU GLY VAL THR ARG ASN LYS ILE SEQRES 3 B 121 MSE THR ALA GLN TYR GLU CYS TYR GLN LYS ILE MSE GLN SEQRES 4 B 121 ASP PRO ILE GLN GLN ALA GLU GLY VAL TYR CYS ASN ARG SEQRES 5 B 121 THR TRP ASP GLY TRP LEU CYS TRP ASN ASP VAL ALA ALA SEQRES 6 B 121 GLY THR GLU SER MSE GLN LEU CYS PRO ASP TYR PHE GLN SEQRES 7 B 121 ASP PHE ASP PRO SER GLU LYS VAL THR LYS ILE CYS ASP SEQRES 8 B 121 GLN ASP GLY ASN TRP PHE ARG HIS PRO ALA SER ASN ARG SEQRES 9 B 121 THR TRP THR ASN TYR THR GLN CYS ASN VAL ASN THR HIS SEQRES 10 B 121 GLU LYS VAL LYS MODRES 3AQF MSE A 76 MET SELENOMETHIONINE MODRES 3AQF MSE A 88 MET SELENOMETHIONINE MODRES 3AQF MSE B 42 MET SELENOMETHIONINE MODRES 3AQF MSE B 53 MET SELENOMETHIONINE MODRES 3AQF MSE B 85 MET SELENOMETHIONINE HET MSE A 76 8 HET MSE A 88 8 HET MSE B 42 8 HET MSE B 53 8 HET MSE B 85 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 5(C5 H11 N O2 SE) FORMUL 3 HOH *30(H2 O) HELIX 1 1 ASN A 60 ASP A 77 1 18 HELIX 2 2 PRO A 78 TRP A 83 5 6 HELIX 3 3 ASP A 85 PHE A 107 1 23 HELIX 4 4 ASN A 113 HIS A 127 1 15 HELIX 5 5 VAL B 36 ASP B 55 1 20 HELIX 6 6 ASN B 128 HIS B 132 5 5 SHEET 1 A 2 TYR B 64 CYS B 65 0 SHEET 2 A 2 VAL B 78 ALA B 79 -1 O VAL B 78 N CYS B 65 SHEET 1 B 2 THR B 68 TRP B 69 0 SHEET 2 B 2 CYS B 74 TRP B 75 -1 O TRP B 75 N THR B 68 SHEET 1 C 2 THR B 82 LEU B 87 0 SHEET 2 C 2 LYS B 100 CYS B 105 -1 O VAL B 101 N GLN B 86 SSBOND 1 CYS A 68 CYS A 99 1555 1555 2.02 SSBOND 2 CYS A 84 CYS A 131 1555 1555 2.04 SSBOND 3 CYS B 48 CYS B 74 1555 1555 2.05 SSBOND 4 CYS B 65 CYS B 105 1555 1555 2.03 SSBOND 5 CYS B 88 CYS B 127 1555 1555 2.04 LINK C GLN A 75 N MSE A 76 1555 1555 1.32 LINK C MSE A 76 N ASP A 77 1555 1555 1.33 LINK C ALA A 87 N MSE A 88 1555 1555 1.33 LINK C MSE A 88 N ILE A 89 1555 1555 1.33 LINK C ILE B 41 N MSE B 42 1555 1555 1.33 LINK C MSE B 42 N THR B 43 1555 1555 1.32 LINK C ILE B 52 N MSE B 53 1555 1555 1.32 LINK C MSE B 53 N GLN B 54 1555 1555 1.33 LINK C SER B 84 N MSE B 85 1555 1555 1.33 LINK C MSE B 85 N GLN B 86 1555 1555 1.33 CISPEP 1 PHE A 111 PRO A 112 0 0.04 CRYST1 55.424 55.424 119.391 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018043 0.000000 0.000000 0.00000 SCALE2 0.000000 0.018043 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008376 0.00000